Camilo Molina, MD

Camilo A. Molina, MD, FAANS

Specializes In
  • Neurosurgery
  • Spine Surgery
Languages Spoken
  • English
  • Spanish


Sees Patients For

Spinal deformities, spinal tumors, cervical spine deformity, cervical spine disease, degenerative spine disease, spinal stenosis, spinal trauma, minimally invasive spine surgery

Hospital Affiliations

  • Barnes-Jewish Hospital
  • Barnes-Jewish West County Hospital



Academic Title(s)

Assistant Professor, Neurosurgery and Orthopedic Surgery
Deputy Director, Spine Innovation, Center for Innovation in Neuroscience and Technology
Director, Spinal Deformity and Spinal Oncology
Co-Director, Patient Safety and Quality Improvement
Co-Director, Complex Spine Fellowship

Research Interests

Dr. Molina is a spine fellowship-trained neurosurgeon with dedicated complex spine deformity and oncology training. He specializes in the entire spectrum of spine disease, but has a unique interest in spinal tumors and spinal deformities. He has an active laboratory devoted to the study of spinal cord injury, spinal oncology, spinal deformity and enabling spine surgery technologies. His clinical and research vision converges on the mission of providing his patients an avenue to return to their lives in the least disruptive manner. He is an expert and lead developer in novel robotic and augmented reality spine surgery solutions. He was a leader on the clinical design team that ultimately led to the FDA approval and performance of the first augmented reality mediated spine procedures in the United States.

Publications & Research

View research profile »


Fellowship: Complex Spine

2020 Johns Hopkins Hospital, Baltimore, MD

Residency: Neurosurgery

2019 Johns Hopkins Hospital, Baltimore, MD

Medical Degree

2013 Johns Hopkins University School of Medicine, Baltimore, MD

Financial Disclosures
  • Augmedics
    • Equity: Yes
    • Reporting Date: 05/01/2024
  • Kinexus
    • Equity: Yes
    • Reporting Date: 05/01/2024
  • Stryker
    • Speaker Fees: $10,000 - $19,999
    • Reporting Date: 05/01/2024

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.